|
HNRNPUL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2132000000008E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60840999999801E-05 |
| Normal-vs-Stage2 |
5.041800E-03 |
| Normal-vs-Stage3 |
7.360700E-03 |
| Normal-vs-Stage4 |
1.961510E-02 |
| Stage1-vs-Stage2 |
9.771000E-01 |
| Stage1-vs-Stage3 |
9.422800E-01 |
| Stage1-vs-Stage4 |
3.700400E-01 |
| Stage2-vs-Stage3 |
9.745400E-01 |
| Stage2-vs-Stage4 |
3.714000E-01 |
| Stage3-vs-Stage4 |
3.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10959999999982E-05 |
| Normal-vs-AfricanAmerican |
3.675300E-03 |
| Normal-vs-Asian |
9.992000E-02 |
| Caucasian-vs-AfricanAmerican |
7.283800E-01 |
| Caucasian-vs-Asian |
8.227400E-01 |
| AfricanAmerican-vs-Asian |
9.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50119999986487E-07 |
| Normal-vs-Female |
4.650800E-01 |
| Male-vs-Female |
2.647100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.996200E-03 |
| Normal-vs-Extreme_Weight |
4.92730000023478E-07 |
| Normal-vs-Obese |
3.614400E-02 |
| Normal-vs-Extreme_Obese |
1.262090E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.303200E-01 |
| Normal_Weight-vs-Obese |
2.701000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.806000E-01 |
| Extreme_Weight-vs-Obese |
1.527830E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.283000E-01 |
| Obese-vs-Extreme_Obese |
1.609580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.451600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.018000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.34310000002402E-06 |
| Normal-vs-Age(81-100Yrs) |
2.605400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.970400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.884780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.018030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.429170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.043600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.625000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.31480000000484E-05 |
| Normal-VS-Type2 PRCC |
1.18920000002909E-06 |
| Normal-VS-KIRP CIMP |
3.116000E-01 |
| Normal-VS-Unclassified PRCC |
1.734030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.274040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.003600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.974220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.813830E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.087700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.382800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.28410000000712E-05 |
| Normal-vs-N1 |
1.009370E-01 |
| Normal-vs-N2 |
2.156700E-03 |
| N0-vs-N1 |
1.876450E-01 |
| N0-vs-N2 |
4.844200E-01 |
| N1-vs-N2 |
2.068500E-02 |
|
|
